0001209191-19-054530.txt : 20191030 0001209191-19-054530.hdr.sgml : 20191030 20191030170558 ACCESSION NUMBER: 0001209191-19-054530 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191029 FILED AS OF DATE: 20191030 DATE AS OF CHANGE: 20191030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Edwards Jonathan S. CENTRAL INDEX KEY: 0001791944 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39094 FILM NUMBER: 191181045 MAIL ADDRESS: STREET 1: C/O PHATHOM PHARMACEUTICALS, INC. STREET 2: 2150 E. LAKE COOK ROAD, SUITE 800 CITY: BUFFALO GROVE STATE: IL ZIP: 60089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phathom Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001783183 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824151574 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 E. LAKE COOK ROAD, SUITE 800 CITY: BUFFALO GROVE STATE: IL ZIP: 60089 BUSINESS PHONE: 650-325-5156 MAIL ADDRESS: STREET 1: 2150 E. LAKE COOK ROAD, SUITE 800 CITY: BUFFALO GROVE STATE: IL ZIP: 60089 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-29 0 0001783183 Phathom Pharmaceuticals, Inc. PHAT 0001791944 Edwards Jonathan S. C/O PHATHOM PHARMACEUTICALS, INC. 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089 1 0 0 0 Common Stock 2019-10-29 4 C 0 991672 15.20 A 991672 I By Medicxi Growth I LP Common Stock 2019-10-29 4 C 0 23558 15.20 A 23558 I By Medicxi Growth Co-Invest I LP Common Stock 2019-10-29 4 P 0 1028205 19.00 A 2019877 I By Medicxi Growth I LP Common Stock 2019-10-29 4 P 0 24426 19.00 A 47984 I By Medicxi Growth Co-Invest I LP Convertible Promissory Notes 15.20 2019-10-29 4 C 0 15073416.76 0.00 D 2020-05-07 Common Stock 991672 0 I By Medicxi Growth I LP Convertible Promissory Notes 15.20 2019-10-29 4 C 0 358090.10 0.00 D 2020-05-07 Common Stock 23558 0 I By Medicxi Growth Co-Invest I LP Immediately prior to the closing of the Issuer's initial public offering, the outstanding principal and unpaid accrued interest due on the Convertible Promissory Notes automatically converted into shares of the Issuer's Common Stock. Held by Medicxi Growth I LP ("Medicxi Growth I"). Medicxi Growth I GP Limited ("Medicxi Growth I GP") is the sole general partner of Medicxi Growth I, and Medicxi Ventures Management (Jersey) Limited ("Medicxi Manager") is the manager of Medicxi Growth I and Medicxi Growth Co-Invest I LP ("Medicxi Growth Co-Invest I"). The Reporting Person is a partner of an affiliate of Medicxi Manager. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose. Held by Medicxi Growth Co-Invest I. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth Co-Invest I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose. Exhibit 24 - Power of Attorney (incorporated by reference to Exhibit 24 - Power of Attorney included on the Form 3, filed with the SEC on October 24, 2019). /s/ David Socks, Attorney-in-Fact 2019-10-30